Science rap mastermind, Tom McFadden, recently worked with high school students in the bay area to create a plasmid rap video for us (If you’re new to plasmids, we highly recommend checking out the video). Tom has made many more Science rap videos to teach students around the globe and is pushing SciComm further with his new company, Science with Tom. In this podcast, we learn more about Tom and pick his brain for advice on how to dive into new forms of science communication.
In this episode of the Addgene Podcast, we sit down with Kwabena Duedu, a researcher at the University of Health and Allied Sciences in Ghana. He’s done research at a number of institutions in Ghana and most recently got his PhD in cell and molecular biology at the University of Edinburgh where he worked on developing novel systems for bioconversion of cellulosic biomass to useful products under Professor Christopher E. French.
Dr. Duedu was recently awarded plasmids from Addgene as a successful applicant to the Addgene, Seeding Labs Plasmid Grant. For this grant, we’re working with fellow nonprofit, Seeding Labs, to distribute plasmids to researchers in developing regions and thereby accelerate their research. Kwabena came across the plasmid grant in Seeding Lab’s Newsletter and recently visited Cambridge to spend some time learning and doing research at Novartis.
Listen to learn how Kwabena plans to use his research experiences as well as plasmids from Addgene to bring new opportunities to Ghanaian scientists
In the third installment in our podcast series, we chat with new Addgene Board Member, Michael Koeris. Dr. Koeris did his graduate work in Professor Jim Collins' lab (then at Boston University, now at MIT) where he worked on understanding bacterial antibiotic resistance. During this time, Dr. Koeris and Professor Timothy Lu (a graduate student in the Collins' lab at the time) got the idea to engineer bacteriophage (viruses that infect bacteria) for use as antibiotics. To develop this idea, Drs. Koeris and Lu founded the biotech startup company, Novophage. As you'll hear Dr. Koeris explain however, the time was not right for the development of phage-based therapeutics. After a brief stint at the venture capital firm, Flagship Ventures, Koeris helped change Novophage's focus. The company went from developing therapeutics to developing phage-based tools for detecting pathogens in food products. Along the way, the company changed its name from Novophage to Sample 6.
We recently sat down with Addgene Board Member, depositor, and Harvard Medical School researcher Connie Cepko. Listen to the podcast below to hear all about the research being conducted in Professor Cepko's lab and to get some insight into her management and mentoring styles. If you'd like to learn more about Professor Cepko's recent work on developing GFP-activated proteins, read our recent blog post.
This article is based on an interview with Novartis researcher, Carrie Bhang.
The ClonTracer Library, deposited by Carrie Bhang, a research investigator in the In Vivo Pharmacology group at Novartis Oncology, is an exciting new tool that allows researchers to individually label millions of mammalian cells through lentiviral infection and to monitor their abundance and clonal dynamics over time using next generation sequencing (NGS). The library was developed when Carrie was a post-doc in Frank Stegmeier’s lab in Novartis Oncology.